Xenon Pharmaceuticals (XENE) Tax Provisions (2018 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Tax Provisions of -$2.6 million for Q1 2026, down 702.11% year-over-year from $427000.0 in Q1 2025, and down 168.82% quarter-over-quarter from $3.7 million in Q4 2025.
Powered by 
Analysis
Xenon Pharmaceuticals (XENE) Tax Provisions (2018 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Tax Provisions for 9 consecutive years, with -$2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions fell 702.11% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at $1.2 million (up 129.85% YoY), while the FY2025 annual figure was $4.2 million, up 203.06% from the prior year.
- Tax Provisions fell to -$2.6 million in Q1 2026 per XENE's latest filing, from $3.7 million in the prior quarter.
- Across five years, Tax Provisions topped out at $3.7 million in Q4 2025 and bottomed at -$3.8 million in Q4 2024.
- Historically, Tax Provisions has averaged -$151529.4 across 5 years, with a median of -$205000.0 in 2023.
- Annual changes were most pronounced in 2024 — Tax Provisions sank 1777.07% — and 2025, when it surged 311.56%.
- Xenon Pharmaceuticals' Tax Provisions stood at $1.2 million in 2022, then sank by 117.33% to -$205000.0 in 2023, then tumbled by 1777.07% to -$3.8 million in 2024, then surged by 197.09% to $3.7 million in 2025, then tumbled by 168.82% to -$2.6 million in 2026.
- Business Quant data shows XENE's Tax Provisions at -$2.6 million in Q1 2026, $3.7 million in Q4 2025, and $677000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Xenon Pharmaceuticals | 5.94 Bn | 5.94 Bn | - | -585,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -585,000.00 |
| Mar 31, 2026 | -2.57 Mn |
| Dec 31, 2025 | -52.21 Mn |
| Sep 30, 2025 | 677,000.00 |
| Jun 30, 2025 | -626,000.00 |
| Mar 31, 2025 | 427,000.00 |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | -320,000.00 |
| Jun 30, 2024 | -333,000.00 |
| Mar 31, 2024 | 412,000.00 |
| Dec 31, 2023 | -205,000.00 |
| Sep 30, 2023 | -157,000.00 |
| Jun 30, 2023 | -220,000.00 |
| Mar 31, 2023 | 290,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | -587,000.00 |
| Jun 30, 2022 | -40,000.00 |
| Mar 31, 2022 | -394,000.00 |
| Dec 31, 2021 | -20.81 Mn |
| Sep 30, 2021 | -205,000.00 |